Modison Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 18, 2025, 8:58 pm

Competitors of Modison Ltd

All Competitor Stocks of Modison Ltd

Quarterly Result

Last Updated: August 19, 2025, 12:55 pm

Below is a detailed analysis of the quarterly data for Modison Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 134.14 Cr.. The value appears strong and on an upward trend. It has increased from 130.07 Cr. (Mar 2025) to 134.14 Cr., marking an increase of 4.07 Cr..
• For Expenses, as of Jun 2025, the value is 125.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.70 Cr. (Mar 2025) to 125.57 Cr., marking an increase of 10.87 Cr..
• For Operating Profit, as of Jun 2025, the value is 8.57 Cr.. The value appears to be declining and may need further review. It has decreased from 15.37 Cr. (Mar 2025) to 8.57 Cr., marking a decrease of 6.80 Cr..
• For OPM %, as of Jun 2025, the value is 6.39%. The value appears to be declining and may need further review. It has decreased from 11.82% (Mar 2025) to 6.39%, marking a decrease of 5.43%.
• For Other Income, as of Jun 2025, the value is 2.19 Cr.. The value appears strong and on an upward trend. It has increased from 1.77 Cr. (Mar 2025) to 2.19 Cr., marking an increase of 0.42 Cr..
• For Interest, as of Jun 2025, the value is 2.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.69 Cr. (Mar 2025) to 2.07 Cr., marking an increase of 0.38 Cr..
• For Depreciation, as of Jun 2025, the value is 2.28 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.41 Cr. (Mar 2025) to 2.28 Cr., marking a decrease of 0.13 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.41 Cr.. The value appears to be declining and may need further review. It has decreased from 13.04 Cr. (Mar 2025) to 6.41 Cr., marking a decrease of 6.63 Cr..
• For Tax %, as of Jun 2025, the value is 25.27%. The value appears to be improving (decreasing) as expected. It has decreased from 26.84% (Mar 2025) to 25.27%, marking a decrease of 1.57%.
• For Net Profit, as of Jun 2025, the value is 4.80 Cr.. The value appears to be declining and may need further review. It has decreased from 9.54 Cr. (Mar 2025) to 4.80 Cr., marking a decrease of 4.74 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.48. The value appears to be declining and may need further review. It has decreased from 2.94 (Mar 2025) to 1.48, marking a decrease of 1.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:51 pm

Growth

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: September 10, 2025, 3:58 pm

Below is a detailed analysis of the balance sheet data for Modison Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 13.00 Cr..
• For Borrowings, as of Mar 2025, the value is 73.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 32.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 41.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing). It has decreased from 36.00 Cr. (Mar 2024) to 30.00 Cr., marking a decrease of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 319.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 271.00 Cr. (Mar 2024) to 319.00 Cr., marking an increase of 48.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 92.00 Cr., marking an increase of 13.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 223.00 Cr.. The value appears strong and on an upward trend. It has increased from 180.00 Cr. (Mar 2024) to 223.00 Cr., marking an increase of 43.00 Cr..
• For Total Assets, as of Mar 2025, the value is 319.00 Cr.. The value appears strong and on an upward trend. It has increased from 271.00 Cr. (Mar 2024) to 319.00 Cr., marking an increase of 48.00 Cr..

Notably, the Reserves (213.00 Cr.) exceed the Borrowings (73.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Modison Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.61. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 7.61, marking an increase of 1.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.61. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 7.61, marking an increase of 1.03.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.08. This value is within the healthy range. It has increased from 8.52 (Mar 24) to 10.08, marking an increase of 1.56.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.65. It has increased from 62.58 (Mar 24) to 66.65, marking an increase of 4.07.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.75. It has increased from 62.68 (Mar 24) to 66.75, marking an increase of 4.07.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.08. It has increased from 124.67 (Mar 24) to 151.08, marking an increase of 26.41.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.94. This value is within the healthy range. It has increased from 10.06 (Mar 24) to 14.94, marking an increase of 4.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.47. This value is within the healthy range. It has increased from 8.13 (Mar 24) to 12.47, marking an increase of 4.34.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.34. This value is within the healthy range. It has increased from 8.98 (Mar 24) to 10.34, marking an increase of 1.36.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.61. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 7.61, marking an increase of 1.03.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.61. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 7.61, marking an increase of 1.03.
• For PBDIT Margin (%), as of Mar 25, the value is 9.88. This value is below the healthy minimum of 10. It has increased from 8.07 (Mar 24) to 9.88, marking an increase of 1.81.
• For PBIT Margin (%), as of Mar 25, the value is 8.25. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 8.25, marking an increase of 1.74.
• For PBT Margin (%), as of Mar 25, the value is 6.84. This value is below the healthy minimum of 10. It has decreased from 7.20 (Mar 24) to 6.84, marking a decrease of 0.36.
• For Net Profit Margin (%), as of Mar 25, the value is 5.03. This value is within the healthy range. It has decreased from 5.28 (Mar 24) to 5.03, marking a decrease of 0.25.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.03. This value is below the healthy minimum of 8. It has decreased from 5.28 (Mar 24) to 5.03, marking a decrease of 0.25.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.41. This value is below the healthy minimum of 15. It has increased from 10.52 (Mar 24) to 11.41, marking an increase of 0.89.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.99. This value is within the healthy range. It has increased from 12.62 (Mar 24) to 17.99, marking an increase of 5.37.
• For Return On Assets (%), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 7.87 (Mar 24) to 7.73, marking a decrease of 0.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.15 (Mar 24) to 0.33, marking an increase of 0.18.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.66. It has increased from 1.64 (Mar 24) to 1.66, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has decreased from 2.74 (Mar 24) to 2.32, marking a decrease of 0.42.
• For Quick Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.96, marking a decrease of 0.24.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.39. This value is within the healthy range. It has decreased from 4.63 (Mar 24) to 4.39, marking a decrease of 0.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 46.01. This value is within the healthy range. It has increased from 22.78 (Mar 24) to 46.01, marking an increase of 23.23.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 34.73. This value is within the healthy range. It has increased from 17.60 (Mar 24) to 34.73, marking an increase of 17.13.
• For Earning Retention Ratio (%), as of Mar 25, the value is 53.99. This value is within the healthy range. It has decreased from 77.22 (Mar 24) to 53.99, marking a decrease of 23.23.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 65.27. This value is within the healthy range. It has decreased from 82.40 (Mar 24) to 65.27, marking a decrease of 17.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.32. This value is within the healthy range. It has decreased from 11.55 (Mar 24) to 8.32, marking a decrease of 3.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.42. This value is within the healthy range. It has decreased from 6.58 (Mar 24) to 5.42, marking a decrease of 1.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 470.20. It has increased from 410.95 (Mar 24) to 470.20, marking an increase of 59.25.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.95, marking a decrease of 0.07.
• For EV / EBITDA (X), as of Mar 25, the value is 9.70. This value is within the healthy range. It has decreased from 12.59 (Mar 24) to 9.70, marking a decrease of 2.89.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.81, marking a decrease of 0.13.
• For Retention Ratios (%), as of Mar 25, the value is 53.98. This value is within the healthy range. It has decreased from 77.21 (Mar 24) to 53.98, marking a decrease of 23.23.
• For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 1.87 (Mar 24) to 1.84, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.81, marking a decrease of 0.13.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness